Accretion Nutraveda IPO GMP & Review: Apply or Avoid?

Accretion Nutraveda IPO is open for bidding from 28th January 2026 to 30th January 2026. It is a bookbuilding IPO of ₹24.77 crore, comprising an entirely fresh issue of 0.10 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 4th February 2026. 

Accretion Nutraveda IPO Details 

The Accretion Nutraveda IPO date is fixed between 28th January 2026 to 30th January 2026. The face value of Accretion Nutraveda shares stands at ₹10 per share, and the IPO Issue price band is set at ₹122 to ₹129 per share

Kfin Technologies Limited is the registrar of the Accretion Nutraveda IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below. 

Accretion Nutraveda IPO Share Reservation

Riddhi Display Equipment’s IPO is a bookbuilding issue of 0.19 crore shares worth ₹24.77 crore. Accretion Nutraveda IPO Limited shares will be listed on the BSE and the SME Exchange. Furthermore, SEBI has specified the share reservation criteria for different investor categories. 

Accretion Nutraveda IPO GMP Grey Market Premium

GMP is the gap between the issue price band and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the Accretion Nutraveda IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

As of 28th January 2026, Accretion Nutraveda IPO GMP stands at ₹0.00 per share, which means the share will likely list at ₹129.00 on its tentative listing date, 4th February 2026.

GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the Accretion Nutraveda IPO GMP. Stay informed with Univest for real-time insights into IPOs and their GMP trends. 

Accretion Nutraveda IPO GMP Review

Check out the detailed Accretion Nutraveda GMP IPO review for a thorough understanding of its potential to report listing gains on 4th February 2026. The Accretion Nutraveda IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO. 

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the business’s economic growth and decline before applying for the Accretion Nutraveda IPO.

Accretion Nutraveda Limited’s revenue increased by 208.84% from ₹5.20 crores in March 2024 to ₹16.06 crores in March 2025. Moreover, the company’s PAT decreased by 218.29% from ₹0.82 crores in March 2024 to ₹2.61 crores in March 2025.

Accretion Nutraveda’s IPO has shown consistent revenue growth, indicating the company’s financial stability. Moreover, brokers, investors, and RAs have a positive outlook for the Accretion Nutraveda IPO, with its tentative listing day set for 4th February 2026. 

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technicals of the Accretion Nutraveda IPO.

The P/E ratio of Accretion Nutraveda Limited shares is 26.27, and its Earnings Per Share (EPS) stands at 4.91. Thus, the Accretion Nutraveda IPO can deliver gains on its tentative listing date, 4th February 2026. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Accretion Nutraveda Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

Accretion Nutraveda IPO Subscription Status

The Accretion Nutraveda IPO will open for bidding on 28th January 2026. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Accretion Nutraveda IPO Subscription Status. 

About Accretion Nutraveda Limited

Accretion Nutraveda Limited was established in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products in various dosage forms, including tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels The company operates as a Contract Development and Manufacturing Organization (CDMO), serving both domestic and international markets such as Sri Lanka, Singapore, and the USA. Its products combine classical Ayurvedic principles with modern nutraceutical science to address areas like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness.

Business verticals:

1. Domestic Sales & Merchant Exports (Loan License Basis)– contributing 96.62% of total revenue in FY 2024-25.
2. Direct Exports– Contributing 38%, showing consistent growth.

It has a manufacturing facility in Gujarat that covers about 10,763 sq. ft., equipped with modern infrastructure, including 13 air handling units, separate processing areas, and quality control systems. The facility is GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal certified, with an FSSAI license.

Accretion Nutraveda Limited Financials

The company’s financial analysis is essential before applying for the Accretion Nutraveda IPO. See the table for Accretion Nutraveda Limited’s financials. 

Explanation

Accretion Nutraveda Limited’s revenue increased by 208.84% from ₹5.20 crores in March 2024 to ₹16.06 crores in March 2025. Moreover, the company’s PAT decreased by 218.29% from ₹0.82 crores in March 2024 to ₹2.61 crores in March 2025.

Accretion Nutraveda Limited IPO Promoter Holdings

Have a look at the table below to check the holdings of Ashish Kankaria, Shruti A. Kankaria, Ambica Capital Markets Limited, and Gold View Financial Services Limited.

Note: The value will be calculated using Equity Dilution = Share Holding Pre Issue – Share Holding Post Issue.

Aim of the Accretion Nutraveda IPO

The primary aim of the Accretion Nutraveda IPO is to raise ₹24.77 crores. On the other hand, Accretion Nutraveda has decided to utilise these funds in different ways.

• To purchase machinery for Automation in the existing Manufacturing unit
• To Purchase Machinery for the New Manufacturing Setup
• To General Corporate Expenses.
• To fund the working capital requirements of our company

Should I Invest in the Accretion Nutraveda IPO?

Explore the pros and cons of Accretion Nutraveda to know whether you should apply or avoid the issue. These pros and cons might help you understand the IPO’s efficiency in delivering profits over the coming decades. 

Pros of the Accretion Nutraveda IPO

• The company has experienced promoters and a management Team
• The company has a Diverse product portfolio
• The company has established a business process and management framework
• The company has relationships with clients and suppliers

Cons of the Accretion Nutraveda IPO

• The company has a Very Short Operating History & Execution Risk
• The company has an Operational Disruption Risk
• The company has a Customer & Supplier Concentration

How to Apply for the Accretion Nutraveda IPO?

Check the steps mentioned below to apply for Accretion Nutraveda Ltd.

• Step 1: Conduct thorough research on the Accretion Nutraveda IPO GMP, subscription status, issue size, lot size, and other details. 
• Step 2: Open a demat account with Univest to access real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
• Step 3: Make a bid for 2 lots of 2,000 shares worth ₹2,58,000
• Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for the Accretion Nutraveda IPO across multiple demat accounts to increase your chances of allotment. 

How to Check the Accretion Nutraveda IPO Allotment Status?

You can check for the Accretion Nutraveda IPO allotment in different ways. These include BSE and the registrar portal. Follow the steps below to check your allotment status online.

Check On BSE

• Visit the BSE Official Site
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose the Accretion Nutraveda IPO.  
• Choose whether to proceed with the PAN number or the application number.
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal.
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your Accretion Nutraveda IPO allotment status.

Let’s Wrap

Accretion Nutraveda IPO is a bookbuilding issue of shares worth ₹24.77 crores. The shares of Accretion Nutraveda Limited will be listed on BSE and SME on its tentative listing date of 4th February 2026. Researching the Accretion Nutraveda IPO GMP and reviews is highly recommended to achieve your desired profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.

Open a demat account on Univest now to initiate your investment journey!

FAQs on Accretion Nutraveda IPO

How is the Accretion Nutraveda IPO?

Ans. Currently, on 28th January 2026, the Accretion Nutraveda GMP (Grey Market Premium) stands at ₹0. It indicates that the estimated listing price could be ₹129 per share. It is a bookbuilding IPO of ₹24.77 shares. The face value of each Accretion Nutraveda share is ₹10 per share. 

What is the Accretion Nutraveda IPO price?

Ans. The Accretion Nutraveda IPO issue price band is set at ₹122 to ₹129 per share. 

Is the Accretion Nutraveda IPO a good investment?

Ans. Accretion Nutraveda Limited’s revenue increased by 208.84% from ₹5.20 crores in March 2024 to ₹16.06 crores in March 2025. Moreover, the company’s PAT decreased by 218.29% from ₹0.82 crores in March 2024 to ₹2.61 crores in March 2025.

Who is the registrar of the Accretion Nutraveda IPO?

Ans. Kfin Technologies Limited is the registrar for the Accretion Nutraveda IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Accretion Nutraveda allotment and refund, you can contact Kfin Technologies Limited at apl.ipo@kfintech.com or at 04067162222, 04079611000.

What is the issue size of the Accretion Nutraveda IPO? 

Ans. Accretion Nutraveda IPO is a bookbuilding IPO of ₹24.77 crores. Moreover, the IPO is set to open on 28th January 2026 and close on 30th January 2026. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Accretion Nutraveda IPO, download the Accretion Nutraveda IPO RHP and Accretion Nutraveda IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Upcoming IPOs

Current & Previous IPOs

Read Our Articles on the Best Stocks

Tech Stocks in India to Invest in 2025 | Tech Sector Stocks 

Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks 

Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks 

Paint Stocks in India to Invest in 2025 | Paint Sector Stocks 

Paper Stocks in India to Invest in 2025 | Paper Sector Stocks 

Best Semiconductor Stocks in India 2025 

Best Large Cap Stocks in India 2025 

Green Energy Penny Stocks

Best Cement Stocks To Invest In India

Also Explore

Univest Screeners

Explore Webstories on Univest 

Best Time To Buy Dividend Stocks

How RBI Policies Affect Dividend Stocks

Can Dividend Stocks Beat Inflation

What Is The Dividend Aristocrat List

Which Indian Psus Offer The Best Dividends

Large Cap Vs Small Cap Dividend Stocks